Author Details

Филоненко, Дарья Александровна

Issue Section Title File
Vol 19, No 4 (2017) Articles Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case PDF
(Rus)
Vol 22, No 2 (2020) Best Practice SDH-deficient gastrointestinal stromal tumors: paradoxical effect of imatinib PDF
(Rus)
Vol 22, No 4 (2020) CLINICAL ONCOLOGY Avapritinib: a new tyrosine kinase inhibitor for treatment of advanced gastrointestinal stromal tumors. The literature review and clinical case PDF
(Rus)
Vol 23, No 4 (2021) CLINICAL ONCOLOGY Metastatic gastrointestinal stromal tumor of the greater omentum. Case report PDF
(Rus)
Vol 23, No 4 (2021) CLINICAL ONCOLOGY The consensus on the prevention and correction of rash in patients with HR+ HER2- metastatic breast cancer treated with alpelisib PDF
(Rus)
Vol 24, No 3 (2022) CLINICAL ONCOLOGY Antitumor response and quality of life: is there a need to sacrifice? Clinical observation: long-term and safe control of the disease using a combination of ribociclib with letrozole. Case report PDF
(Rus)
Vol 26, No 2 (2024) Articles Effect of internal subtype on the efficacy of CDK4/6 inhibitor therapy in advanced HR+/HER2breast cancer: A review PDF
(Rus)
Vol 27, No 1 (2025) Articles Evolution of anti-HER2 therapy in advanced HER2+ breast cancer or “why is trastuzumab still a key player?”. A review PDF
(Rus)
Vol 26, No 3 (2024) Articles Retrospective analysis of the safety and efficacy of Pembroria® during non-medical switching from the original drug Keytruda® in patients with advanced malignancies of various localizations in real clinical practice PDF
(Rus)